These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1470214)

  • 1. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT; Threlkeld PG; Bymaster FP
    Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term effects of neuroleptics.
    Adv Biochem Psychopharmacol; 1980; 24():1-607. PubMed ID: 6105766
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronology of neurochemical alterations induced by GABA agonist administration.
    Enna SJ; Ferkany JW; Butler IJ
    Adv Biochem Psychopharmacol; 1981; 26():181-9. PubMed ID: 7457233
    [No Abstract]   [Full Text] [Related]  

  • 10. Methamphetamine: toxicity to dopaminergic neurons.
    Seiden LS
    NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomifensine-induced increase in extracellular striatal dopamine is enhanced by isoflurane anaesthesia.
    Opacka-Juffry J; Ahier RG; Cremer JE
    Synapse; 1991 Feb; 7(2):169-71. PubMed ID: 2011829
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of rudotel on the synaptic activity of dopaminergic neurons].
    Podgornaia EK; Galkina OV; Il'iuchenok RIu; Poliakov OV
    Eksp Klin Farmakol; 1998; 61(4):10-1. PubMed ID: 9783098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-substituted tetralin derivatives as conformationally restricted butyrophenone analogs.
    Chan CC; Farmer PS; McKenzie G; Robertson H
    Pharmazie; 1987 Jun; 42(6):369-71. PubMed ID: 2890175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
    Nikulina IuA; Skrinskaia IuA; Popova NK
    Biull Eksp Biol Med; 1988 Aug; 106(8):212-4. PubMed ID: 3262000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.
    Waddington JL; O'Boyle KM
    Pharmacol Ther; 1989; 43(1):1-52. PubMed ID: 2675127
    [No Abstract]   [Full Text] [Related]  

  • 17. Catecholamine-independent behavioral and neurochemical effects of cocaine in rats.
    Gale K
    NIDA Res Monogr; 1984; 54():323-32. PubMed ID: 6099878
    [No Abstract]   [Full Text] [Related]  

  • 18. Cocaine abuse: neurochemistry, phenomenology, and treatment.
    Gold MS; Washton AM; Dackis CA
    NIDA Res Monogr; 1985; 61():130-50. PubMed ID: 3932873
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurophysiological approaches to receptor pharmacodynamics.
    White FJ
    NIDA Res Monogr; 1992; 124():35-55. PubMed ID: 1470214
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.